Siga Technologies (SIGA) Total Current Liabilities (2010 - 2025)
Siga Technologies (SIGA) posted Total Current Liabilities of $18.0 million for Q4 2025, down 27.57% on a QoQ basis from $24.8 million in Q3 2025, and down 28.97% year-over-year from $25.3 million in Q4 2024.
Siga Technologies (SIGA) Total Current Liabilities (2010 - 2025) Analysis & Trends
Siga Technologies' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $18.0 million for Q4 2025.
- Quarterly Total Current Liabilities fell 28.97% year-over-year to $18.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.0 million (down 28.97% YoY) and the FY2025 annual result came in at $18.0 million, down 28.97% from the prior year.
- Total Current Liabilities was $18.0 million for Q4 2025 at Siga Technologies, down from $24.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $74.8 million in Q1 2024 and bottomed at $7.2 million in Q1 2022.
- A 5-year average of $24.9 million and a median of $21.9 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities plunged 64.94% — and 2024, when it soared 304.9%.
- Siga Technologies' Total Current Liabilities stood at $30.5 million in 2021, then retreated by 29.42% to $21.5 million in 2022, then jumped by 151.5% to $54.1 million in 2023, then plunged by 53.19% to $25.3 million in 2024, then fell by 28.97% to $18.0 million in 2025.
- Business Quant data shows SIGA's Total Current Liabilities at $18.0 million in Q4 2025, $24.8 million in Q3 2025, and $22.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | 17.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.99 Mn |
| Sep 30, 2025 | 24.84 Mn |
| Jun 30, 2025 | 22.72 Mn |
| Mar 31, 2025 | 27.80 Mn |
| Dec 31, 2024 | 25.33 Mn |
| Sep 30, 2024 | 22.30 Mn |
| Jun 30, 2024 | 21.38 Mn |
| Mar 31, 2024 | 74.81 Mn |
| Dec 31, 2023 | 54.12 Mn |
| Sep 30, 2023 | 30.74 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 21.52 Mn |
| Sep 30, 2022 | 27.46 Mn |
| Jun 30, 2022 | 16.69 Mn |
| Mar 31, 2022 | 7.24 Mn |
| Dec 31, 2021 | 30.49 Mn |
| Sep 30, 2021 | 18.94 Mn |
| Jun 30, 2021 | 7.97 Mn |
| Mar 31, 2021 | 7.51 Mn |